Astrup A, Grunwald GK, Melanson EL, Saris WH & Hill JO (2000) The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord 24, 1545–1552.
Australian Bureau of Statistics (1997) Australian National Nutrition Survey (1995). Catalogue No. 4801.0. Canberra: Australian Government Printing Service.
Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK & Grant AM (2004) Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 8, 1–182.
Boden WE (2000) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86, 19L–22L.
Brinkworth GD, Noakes M, Keogh JB, Luscombe ND, Wittert GA & Clifton PM (2004a) Long-term effects of a high-protein, low-carbohydrate diet on weight control and cardiovascular risk markers in obese hyperinsulinemic subjects. Int Obes Relat Metab Disord 28, 661–670.
Brinkworth GD, Noakes M, Parker B, Foster P & Clifton PM (2004b) Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial. Diabetologia 10, 1677–1686.
Dattilo AM & Kris-Etherton PM (1992) Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 56, 320–328.
Due A, Toubro S, Skov AR & Astrup A (2004) Effect of normal-fat diets, either medium or high in protein, on body weight in overweight subjects: a randomised 1-year trial. Int J Obes Relat Metab Disord 28, 1283–1290.
Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS & Klein S (2003) A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 348, 2082–2090.
Froom P & Goldbourt U (2004) Secular decrease in blood pressure and reduction in mortality from cardiovascular disease in Israeli workers. J Hum Hypertens 18, 113–118.
Garg A (1998) High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 67, 577S–582S.
Hill RJ & Davies PSW (2001) The validity of self-reported energy intake as determined using the doubly labeled water technique. B J Nutr 85, 415–430.
Hokanson JE & Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3, 213–219.
Johnston CS, Tjonn SL & Swan PD (2004) High-protein, low-fat diets are effective for weight loss and favorably alter biomarkers in healthy adults. J Nutr 134, 586–591.
Johnston CS, Tjonn SL, Swan PD, White A, Hutchins H & Sears B (2006) Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets. Am J Clin Nutr 83, 1055–1061.
Knowler WC, Barrett-Connor E, Fowler S, Hamman RF, Lachin JM, Walker EA & Nathan M (2002) Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393–403.
Lejeune MP, Kovacs EM & Westerterp-Plantenga MS (2005) Additional protein intake limits weight regain after weight loss in humans. Br J Nutr 93, 281–289.
Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M & Tuomilehto J (2003) Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study. (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26, 3230–3236.
Luscombe-Marsh ND, Noakes M, Wittert GA, Keogh JB, Foster P & Clifton PM (2005) Carbohydrate-restricted diets high in either monounsaturated fat or protein are equally effective at promoting fat loss and improving blood lipids. Am J Clin Nutr 81, 762–772.
Mainous AG 3rd, Everett CJ, Liszka H, King DE & Egan BM (2004) Prehypertension and mortality in a nationally representative cohort. Am J Cardiol 94, 1496–1500.
Meckling KA, O'Sullivan C & Saari D (2004) Comparison of a low-fat diet to a low-carbohydrate diet on weight loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women. J Clin Endocrinol Metab 89, 2717–2723.
Miller M (2000) Differentiating the effects of raising low levels of high-density lipoprotein cholesterol versus lowering normal triglycerides: further insights from the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86, 23L–27L.
Ridker PM, Hennekens CH, Buring JE & Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342, 836–843.
Ridker PM, Wilson PW & Grundy SM (2004) Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109, 2818–2825.
Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA & Braunwald E (2005) Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352, 20–28.
Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams M, Gracely EJ & Samaha FF (2004) The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 140, 778–785.
Vazquez LA, Pazos F, Berrazueta JR, Fernandez-Escalante C, Garcia-Unzueta MT, Freijanes J & Amado JA (2005) Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 90, 316–322.